Judge blocks US government from slimming down vaccine recommendations

A federal judge has temporarily blocked U.S. Health Secretary Robert F. Kennedy Jr.’s controversial decision to reduce the number of vaccines recommended for children, ruling that Kennedy likely violated federal procedures in restructuring a key vaccine advisory committee.

The ruling, issued Monday by Judge Brian E. Murphy in federal court in Boston, halts Kennedy’s January directive that would have ended broad recommendations for children to be vaccinated against influenza, rotavirus, hepatitis A, hepatitis B, certain forms of meningitis, and respiratory syncytial virus (RSV).

Medical organizations, including the American Academy of Pediatrics (AAP), had warned that scaling back these recommendations would significantly undermine public health protections against these diseases. These groups recently expanded a lawsuit originally filed in July that had initially challenged Kennedy’s decision to stop recommending COVID-19 vaccinations for most children and pregnant women.

As Kennedy implemented additional policy changes that alarmed the medical community, the plaintiffs amended their complaint to address these broader concerns. The lawsuit specifically highlighted Kennedy’s controversial overhaul of the Advisory Committee on Immunization Practices (ACIP), a critical panel that provides guidance to healthcare professionals and the public on vaccination protocols.

Last year, Kennedy, who was a prominent anti-vaccine activist before his appointment as the nation’s top health official, dismissed all 17 members of the original ACIP and replaced them with individuals who included several known anti-vaccine advocates. This move represented an unprecedented shake-up of a committee that has historically been composed of medical experts, epidemiologists, and public health specialists.

Judge Murphy, a Biden nominee, determined that Kennedy’s reconstitution of ACIP likely violated federal law governing advisory committees. The judge’s order not only puts the appointments on hold but also suspends all decisions made by the reformed committee.

“This ruling recognizes the importance of following proper procedures when making decisions that affect public health on a national scale,” said a public health expert familiar with the case who requested anonymity. “The ACIP has historically been composed of independent experts chosen for their scientific credentials, not their ideological positions.”

The committee was scheduled to meet this week to discuss COVID-19 vaccines and other matters, but that meeting has now been postponed following the court’s decision.

“ACIP as currently constituted cannot meet,” explained Richard Hughes IV, an attorney representing the AAP. “How can a committee meet without nearly the entirety of its membership?”

Department of Health and Human Services spokesman Andrew Nixon expressed the administration’s disagreement with the ruling, stating, “HHS looks forward to this judge’s decision being overturned just like his other attempts to keep the Trump administration from governing.”

The temporary injunction represents a significant setback for Kennedy’s attempts to reshape national vaccination policy. Under previous administrations, childhood vaccination recommendations had enjoyed broad bipartisan support, with the CDC’s vaccination schedule credited with drastically reducing the incidence of many once-common childhood diseases.

Medical organizations have consistently emphasized that vaccine recommendations are developed based on extensive clinical trials and safety monitoring. The AAP and other medical societies argue that reducing these recommendations could lead to decreased vaccination rates, potentially causing outbreaks of preventable diseases.

The case highlights the tension between the administration’s approach to public health and the established scientific consensus on childhood vaccinations. Public health experts worry that even temporary changes to vaccination recommendations could have lasting impacts on immunization rates, as parents may receive mixed messages about which vaccines are necessary for their children.

The lawsuit will continue as the court considers the full merits of the case, with potential implications for how federal health agencies make and implement public health recommendations going forward.